RONALD DRENGLER, M.D.
Medical Oncology Physician · SAN ANTONIO, TX
Individual Active NPI 1265459168
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 355 | 371,657 | $30,317,782 | $10,431,099 | $8,321,894 |
| 2023 | 341 | 308,115 | $24,053,661 | $8,215,594 | $6,554,800 |
| 2022 | 337 | 238,641 | $21,455,688 | $7,415,033 | $5,933,150 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J9299 | Injection, nivolumab, 1 mg | 71,260 | $31 | $25 |
| J9263 | Injection, oxaliplatin, 0.5 mg | 32,706 | $0 | $0 |
| J1449 | Injection, eflapegrastim-xnst, 0.1 mg | 22,968 | $26 | $21 |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 21,750 | $1 | $1 |
| J9271 | Injection, pembrolizumab, 1 mg | 19,600 | $56 | $45 |
| J1453 | Injection, fosaprepitant, 1 mg | 18,450 | $0 | $0 |
| J9259 | Injection, paclitaxel protein-bound particles (american regent), not therapeutically equivalent to j9264, 1 mg | 16,706 | $15 | $12 |
| J0897 | Injection, denosumab, 1 mg | 8,040 | $26 | $21 |
| J0185 | Injection, aprepitant, 1 mg | 5,330 | $2 | $1 |
| J9228 | Injection, ipilimumab, 1 mg | 5,150 | $172 | $137 |
| J0461 | Injection, atropine sulfate, 0.01 mg | 4,660 | $0 | $0 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 4,392 | $0 | $0 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Medical Oncology Physician | 207RX0202X | ✓ | J4091 | TX |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Medical Oncology Physician providers in Texas
- NPI 1497319636
- NPI 1730463324
- NPI 1497775365
- NPI 1538162029
- NPI 1104850486
- NPI 1023011624
- NPI 1184627663
- NPI 1255656120
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.